Hypertension (high blood pressure) decisions — 2025

The Board remands the veteran's claims for service connection for various conditions, including rheumatoid arthritis, right hip degenerative joint disease, osteoarthritis, psoriatic arthritis, hypertension, enlarged liver, prostate cancer, diabetes mellitus type II, fever sores, and a compromised immune system, to ensure compliance with prior remand instructions.

The Board remands the claims for service connection for hypertension, prostate disorder, and diabetes mellitus due to further development needed.

The Board denied service connection for a foot condition, bilateral sensorineural hearing loss, back condition, and high blood pressure as the evidence did not support current disabilities or in-service incurrences.

The Board remands the claims for service connection for tinnitus, hypertension, low back disability, bilateral pes planus, and bilateral shin splints to correct duty to assist errors.

The Board remands the claims for service connection for multiple conditions due to inadequate medical opinions and a duty to assist error.

The Board denied service connection for prostate cancer, renal failure, and hypertension as there is no evidence linking these conditions to the Veteran's military service or toxic exposure at Camp Lejeune.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support a higher rating for tinnitus or a compensable rating for bilateral hearing loss. The claim for an acquired psychiatric disability was also denied as there was no current diagnosis of PTSD or other mental health condition.

The Board remands all the issues for further development, including obtaining outstanding VA treatment records and providing additional forms to the Veteran.

The Board denied a compensable initial rating for bilateral hearing loss disability but granted an initial 20 percent rating for bilateral dry eye syndrome. Service connection was denied for obstructive sleep apnea, hypertension, and sinusitis.

The Board dismissed the claims for service connection for left and right upper and lower extremity peripheral neuropathy, glaucoma, as well as erectile dysfunction, vertigo, syncope, fatigue, hypertension, prostate cancer, and a heart disability due to the grant of service connection in an August 2024 rating decision.

The Veteran was granted a 10 percent rating for hypertension from February 15, 2024, and a 70 percent rating for PTSD from November 30, 2021.

The Veteran was granted a 10 percent initial rating for hypertension, effective July 5, 2018.

The Board dismissed several claims for service connection and a higher rating, including those for hypothyroidism, right achilles tendon strain, tinnitus, and erectile dysfunction.

The Board granted service connection for hypertension but denied service connection for a left thigh skin disability.

The Board denied service connection for hypertension, diabetes mellitus, type II (diabetes), and allergic rhinitis, as well as an initial compensable disability rating for sarcoidosis.

The Veteran's service connection for sleep apnea was granted, while the initial evaluation for his hypertension was denied. An effective date of September 20, 2023, was also denied.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) as the evidence did not show that she was unable to secure or follow a substantially gainful occupation due to her service-connected disabilities.

The Board granted service connection for diabetes mellitus and hypertension, both of which are presumed to be related to herbicide exposure during the Veteran's service in Korea.

The Board denied the Veteran's claims for an earlier effective date for service connection for tinnitus and entitlement to service connection for hypertension due to lack of evidence supporting a diagnosis of hypertension and no communication indicating intent to apply for benefits prior to July 17, 2023.

The Board granted service connection for lumbosacral strain, but remanded the claims for headaches, heart disease, hypertension, diabetes mellitus type II, lung disorder, erectile dysfunction, bilateral shoulder disorders, bilateral knee disorders, and bilateral ankle disorders.